Characterizing the Inflammatory Response to Cardiopulmonary Bypass in Children

Annals of Thoracic Surgery

Volumn 81, Issue 6, 2006, Pages

  Kozik, Deborah J ^a,b   Tweddell, James S ^a,b  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ARACHIDONIC ACID; CYTOKINE; DEXAMETHASONE; ENDOTHELIN; KININ; METHYLPREDNISOLONE SODIUM SUCCINATE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TROPONIN I;

ARTICLE; BRAIN DYSFUNCTION; CARDIOPULMONARY ARREST; CARDIOPULMONARY BYPASS; HUMAN; INFLAMMATION; KIDNEY DISEASE; LEUKOCYTE ACTIVATION; PEDIATRIC WARD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STRESS;

AGE FACTORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; APROTININ; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BODY SIZE; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; COMPLEMENT ACTIVATION; CYTOKINES; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; KALLIKREINS; KININS; LYMPHOCYTE ACTIVATION; MALE; MULTIPLE ORGAN FAILURE; ORGAN SPECIFICITY; PLATELET ACTIVATION; RATS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VISCERA;

EID: 33646852780     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.02.073     Document Type: Article

References (78)

1. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 45 (2001) 671-679
2. Seghaye M.C. The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol Young 13 (2003) 228-239
3. Chugani H.T. Biological basis of emotions. brain systems and brain development. Pediatrics 102 (1998) 1225-1229
4. Vidal Melo M.F. Clinical respiratory physiology of the neonate and infant with congenital heart disease. Int Aneseth Clin 42 (2004) 29-43
5. Bestic M., and Reed M.D. The ontogeny of human kidney development. influence on neonatal diuretic therapy. NeoReviews 6 (2005) e363-e368
6. Ulrichs F., and Speer C.P. Neutrophil function in preterm and term infants. NeoReviews 5 (2004) e417-e430
7. Chenoweth D.E., Cooper S.W., Hugli T.E., et al. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304 (1981) 497-503
8. Kirklin J.K., Westaby S., Blackstone E.H., et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86 (1983) 845-857
9. Kirklin J.K., Chenoweth D.E., Naftel D.C., et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 41 (1986) 193-199
10. Steinberg J.B., Kapelanski D.P., Olson J.D., et al. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106 (1993) 1008-1016
11. Moat N.E., Shore D.F., and Evans T.W. Organ dysfunction and cardiopulmonary bypass. the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 7 (1993) 563-573
12. Wachtfogel Y.T., Kucich U., Greenplate J., et al. Human neutrophil degranulation during extracorporeal circulation. Blood 69 (1987) 324-330
13. Antonsen S., Brandslund I., Clemensen S., et al. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 21 (1987) 47-52
14. Wachtfogel Y.T., Harpel P.C., Edmunds Jr. L.H., et al. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass. Blood 73 (1989) 468-471
15. Wachtfogel Y.T., Kucich U., Hack C.E., et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 106 (1993) 1-9
16. Polley M.J., and Nachman R.L. Human platelet activation by C3a and C3a des-arg. J Exp Med 158 (1983) 603-615
17. Edmunds Jr. L.H., Ellison N., Colman R.W., et al. Platelet function during cardiac operations. comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83 (1982) 805-812
18. Tennenberg S.D., Clardy C.W., Bailey W.W., et al. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 50 (1990) 597-601
19. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 106 (1993) 978-987
20. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation. J Thorac Cardiovasc Surg 108 (1994) 29-36
21. Boyle Jr. E.M., Pohlman T.H., Johnson M.C., et al. Endothelial cell injury in cardiovascular surgery. the systemic inflammatory response. Ann Thorac Surg 63 (1997) 277-284
22. Ashraf S.S., Tian Y., Zacharrias S., et al. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J Cardiothorac Surg 12 (1997) 862-868
23. Chew M.S., Brandslund I., Brix-Christensen V., et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass. A descriptive study. Anesthesiology 94 (2001) 745-753
24. Boldt J., Osmer C., Linke L.C., et al. Circulating adhesion molecules in pediatric cardiac surgery. Anesth Analg 81 (1995) 1129-1135
25. Pasnik J., Siniewicz K., Moll J.A., et al. Effect of cardiopulmonary bypass on neutrophil activity in pediatric open-heart surgery. Arch Immunol Ther Exp (Warsz) 53 (2005) 272-277
26. Paret G., Prince T., Keller N., et al. Plasma-soluble E-selectin after cardiopulmonary bypass in children. is it a marker of the postoperative course?. J Cardiothorac Vasc Anesth 14 (2000) 433-437
27. Campbell D.J., Dizon B., Kladis A., et al. Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans. Am J Physiol 281 (2001) R1059-R1070
28. Mojcik C.F., and Levy J.H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71 (2001) 745-754
29. Saatvedt K., Lindberg H., Michelsen S., et al. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children. Scan J Clin Lab Invest 55 (1995) 359-367
30. 2 receptor in a murine model of diffuse brain injury. J Neurotrauma 20 (2003) 841-851
31. Abbott N.J. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20 (2000) 131-147
32. 2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke 28 (1997) 1430-1436
33. Sedrakyan A., Treasure T., Elefteriades J.A., et al. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery. a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
34. Downing S.W., and Edmunds Jr. L.H. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54 (1992) 1236-1243
35. Jansen N.J., van Oeveren W., van den Brock L., et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 102 (1991) 515-525
36. Greeley W.J., Bushman G.A., Kong D.L., et al. Effects of cardiopulmonary bypass on eicosanoids metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg 95 (1988) 842-849
37. Hansen P.R., Svendsen J.H., Hoyer S., et al. Tumor necrosis factor-alpha increases myocardial microvascular transport in vivo. Am J Physiol 266 (1994) H60-H67
38. Oka Y., Murata A., Nishijima J., et al. Circulating interleukin 6 as useful marker for predicting postoperative complications. Cytokine 4 (1992) 298-304
39. Finn A., Naik S., Klein N., et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 105 (1993) 234-241
40. Taniguchi T., Koido Y., Aiboshi J., et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27 (1999) 1262-1264
41. Hovels-Gurich H.H., Schumacher K., Vazquez-Jimenez J.F., et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 73 (2002) 601-608
42. Brix-Christensen V., Petersen T.K., Ravn H.B., et al. Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs. Acta Anaesthesiol Scand 45 (2001) 407-413
43. Adib-Conquy M., Asehnoune K., Moine P., et al. Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol 70 (2001) 30-38
44. Volk H.D., Reinke P., Krausch D., et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22 Suppl 4 (1996) S474-S481
45. Kubes P., Ibbotson G., Russell J., et al. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 259 (1990) G300-G305
46. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass. mechanisms involved and possible therapeutic strategies. Chest 112 (1997) 676-692
47. te Velthuis H., Jansen P.G.M., Oudemans-van Straaten H.M., et al. Circulating endothelin in cardiac operations. influence of blood pressure and endotoxin. Ann Thorac Surg 61 (1996) 904-908
48. Boyle Jr. E.M., Verrier E.D., and Spiess B.D. Endothelial cell injury in cardiovascular surgery. the procoagulant response. Ann Thorac Surg 62 (1996) 1549-1557
49. Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 Suppl (2003) S715-S720
50. Hovels-Gurich H.H., Vazquez-Jimenez J.F., Silvestri A., et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg 124 (2002) 811-820
51. Menasche P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 10 (1995) 597-604
52. Griese M., Wilnhammer C., Jansen S., et al. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants. J Thorac Cardiovasc Surg 118 (1999) 237-244
53. Serraf A., Robotin M., Bonnet N., et al. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 114 (1997) 1061-1069
54. Lassnigg A., Donner E., Grubhofer G., et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11 (2000) 97-104
55. Johnson M.H. Functional brain development in humans. Nat Rev Neurosci 2 (2001) 475-483
56. Mahle W.T. Neurologic and cognitive outcomes in children with congenital heart disease. Curr Opin Pediatr 13 (2001) 482-486
57. Wernovsky G., Shillingford A.J., and Gaynor J.W. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol 20 (2005) 94-99
58. Anand K.J., Hansen D.D., and Hickey P.R. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 73 (1990) 661-670
59. Lodge A.J., Chai P.J., Daggett C.W., et al. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets. timing of dose is important. J Thorac Cardiovasc Surg 117 (1999) 515-522
60. Bronicki R.A., Backer C.L., Baden H.P., et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 69 (2000) 1490-1495
61. Schurr U.P., Zund G., Hoerstrup S.P., et al. Preoperative administration of steroids. influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg 72 (2001) 1316-1320
62. Schroeder V.A., Pearl J.M., Schwartz S.M., et al. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 107 (2003) 2823-2828
63. Checchia P.A., Backer C.L., Bronicki R.A., et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med 31 (2003) 1742-1745
64. Gessler P., Hohl V., Carrel T., et al. Administration of steroids in pediatric cardiac surgery. impact on clinical outcome and systemic inflammatory response. Pediatr Cardiol 26 (2005) 595-600
65. Lindberg L., Forsell C., Jogi P., et al. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br J Anaesth 90 (2003) 728-732
66. Chaney M.A., Nikolov M.P., Blakeman B., et al. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early extubation. Anesth Analg 87 (1998) 27-33
67. Morariu A.M., Loef B.G., Aarts L.P., et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 128 (2005) 2677-2687
68. Gaynor J.W. The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 6 (2003) 128-139
69. Gaynor J.W. Use of modified ultrafiltration after repair of congenital heart defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1 (1998) 81-90
70. Wang M.J., Chiu I.S., Hsu C.M., et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 61 (1996) 651-656
71. Lappegard K.T., Riesenfeld J., Brekke O.L., et al. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoids production. Ann Thorac Surg 79 (2005) 917-923
72. Ueyama K., Nishimura K., Nishina T., et al. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J 50 (2004) 369-372
73. Ikuta T., Fujii H., Shibata T., et al. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg 77 (2004) 1678-1683
74. Gunaydin S., Farsak B., Kocakulak M., et al. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg 74 (2002) 819-824
75. Fitch J.C.K., Rollins S., Matis L., et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 100 (1999) 2499-2506
76. Chai P.J., Nassar R., Oakeley A.E., et al. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage. Circulation 101 (2000) 541-546
77. Barnes P.J., and Karin M. Nuclear factor-kappaB. a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
78. Pearl J.M., Schwartz S.M., Nelson D.P., et al. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg 77 (2004) 994-1000